Immunotherapy With or Without Chemotherapy in Advanced NSCLC-A Delicate Balance of Harm and Benefit
- PMID: 40338569
- DOI: 10.1001/jamaoncol.2025.0897
Immunotherapy With or Without Chemotherapy in Advanced NSCLC-A Delicate Balance of Harm and Benefit
Comment in
-
Harm-Benefit Balance of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.JAMA Oncol. 2025 Jul 1;11(7):707-716. doi: 10.1001/jamaoncol.2025.0985. JAMA Oncol. 2025. PMID: 40338588